Sara Michelmore News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023

HOLLISTER, Calif., Oct. 26, 2023 Alpha Teknova, Inc. , a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular.

United statesMatt lowellSara michelmoreJennifer henryAlpha teknova incGlobenewswire incInvestor relationsChief financial officerMacdougall advisorsMedia contactSenior vice president

Numab Therapeutics Announces First Patient Dosed in Phase 1 Multiple Ascending Dose (MAD) Study of NM26 for Moderate to Severe Atopic Dermatitis

Numab Therapeutics Announces First Patient Dosed in Phase 1 Multiple Ascending Dose (MAD) Study of NM26 for Moderate to Severe Atopic Dermatitis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSara michelmoreDavid urechEuropean unionChief executive officerKaken pharmaceuticalNumab therapeutics

Numab Therapeutics AG: Numab Therapeutics Announces First Patient Dosed in Phase 1 Multiple Ascending Dose (MAD) Study of NM26 for Moderate to Severe Atopic Dermatitis

Numab Therapeutics AG: Numab Therapeutics Announces First Patient Dosed in Phase 1 Multiple Ascending Dose (MAD) Study of NM26 for Moderate to Severe Atopic Dermatitis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSara michelmoreIndiens wirtschaftDavid urechIhre chancenEuropean unionChief executive officerKaken pharmaceuticalExecutive officerDer indienDie highlights

Numab Therapeutics AG: Numab Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of NM26 Program

NM26-2198 is a first-in-class bi-specific antibody designed to simultaneously block multiple targets for the treatment of moderate to severe atopic dermatitis (AD) Combined single ascending dose

United statesDavid urechSara michelmorePeter lichtlenEuropean unionChief executive officerChief medical officerKaken pharmaceuticalWhile kakenExecutive officerDougall advisorsGefallene big techs

Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report

Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoSara michelmore macdougallEric tardifMaravai lifesciencesDeb hart maravai lifesciencesGlobal reporting initiativeAudit committeeHuman servicesMaravai office of scienceMaravai lifesciences holdingsExchange commissionGood healthTraining developmentMaravai lifesciences foundationCommittee of the board directors